Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.815 USD | -1.29% | +12.18% | +50.09% |
05-13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
05-13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.09% | 510M | |
+33.34% | 49.46B | |
+1.79% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.76% | 26.61B | |
-21.85% | 18.64B | |
+7.87% | 13.16B | |
+29.51% | 12.55B | |
+23.72% | 12.1B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- Sector Update: Health Care